Variant report

Variant	esv1839364
Chromosome Location	chr8:1920461-1951163
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:658)
CpG islands
(count:2015)
Chromatin interactive
region (count:14)
LncRNA
region (count:10)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:658 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr8:1949877-1951075	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr8:1949444-1949648	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr8:1921474-1922031	H1-hESC	embryonic stem cell:	n/a	n/a
4	CCNT2	chr8:1921657-1922031	K562	blood:	n/a	n/a
5	CEBPB	chr8:1942047-1942399	HepG2	liver:	n/a	chr8:1942226-1942239 chr8:1942226-1942237 chr8:1942226-1942239
6	CEBPB	chr8:1942036-1942796	IMR90	lung:	n/a	chr8:1942226-1942239 chr8:1942226-1942237 chr8:1942226-1942239
7	CEBPB	chr8:1941969-1942515	A549	lung:	n/a	chr8:1942226-1942239 chr8:1942226-1942237 chr8:1942226-1942239
8	CEBPB	chr8:1942103-1942376	H1-hESC	embryonic stem cell:	n/a	chr8:1942226-1942239 chr8:1942226-1942237 chr8:1942226-1942239
9	CEBPB	chr8:1942182-1942295	Hela-S3	cervix:	n/a	chr8:1942226-1942239 chr8:1942226-1942237 chr8:1942226-1942239
10	CEBPB	chr8:1931727-1931927	HepG2	liver:	n/a	n/a
11	CEBPB	chr8:1942047-1942403	A549	lung:	n/a	chr8:1942226-1942239 chr8:1942226-1942237 chr8:1942226-1942239
12	CEBPB	chr8:1942051-1942407	K562	blood:	n/a	chr8:1942226-1942239 chr8:1942226-1942237 chr8:1942226-1942239
13	CEBPB	chr8:1927713-1927808	HepG2	liver:	n/a	chr8:1927745-1927756
14	CHD1	chr8:1950968-1950973	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD2	chr8:1949818-1950108	H1-hESC	embryonic stem cell:	n/a	n/a
16	CREB1	chr8:1949613-1950373	A549	lung:	n/a	n/a
17	CTBP2	chr8:1949754-1951026	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTCF	chr8:1949420-1949570	Caco-2	colon:	n/a	n/a
19	CTCF	chr8:1926244-1926493	K562	blood:	n/a	n/a
20	CTCF	chr8:1950014-1950121	Spleen_OC	spleen:	n/a	n/a
21	CTCF	chr8:1926280-1926430	HMEC	breast:	n/a	n/a
22	CTCF	chr8:1926300-1926450	AG04450	lung:	n/a	n/a
23	CTCF	chr8:1926300-1926450	HCFaa	heart:	n/a	n/a
24	CTCF	chr8:1921300-1921450	BJ	skin:	n/a	chr8:1921313-1921322
25	CTCF	chr8:1949460-1949610	SAEC	small airway:	n/a	n/a
26	CTCF	chr8:1949459-1949649	Pancreas_OC	pancreas:	n/a	n/a
27	CTCF	chr8:1921280-1921430	HUVEC	blood vessel:	n/a	chr8:1921313-1921322
28	CTCF	chr8:1950058-1950192	MCF-7	breast:	n/a	n/a
29	CTCF	chr8:1926560-1926710	SK-N-SH_RA	brain:	n/a	chr8:1926607-1926620
30	CTCF	chr8:1926233-1926466	Medullo	brain:	n/a	n/a
31	CTCF	chr8:1926180-1926330	HPF	lung:	n/a	n/a
32	CTCF	chr8:1921460-1921610	SAEC	small airway:	n/a	n/a
33	CTCF	chr8:1926220-1926370	NHLF	lung:	n/a	n/a
34	CTCF	chr8:1921220-1921370	AG09319	gingival:	n/a	chr8:1921313-1921322
35	CTCF	chr8:1926280-1926430	HFF-Myc	foreskin:	n/a	n/a
36	CTCF	chr8:1926280-1926430	HEEpiC	esophagus:	n/a	n/a
37	CTCF	chr8:1949440-1949590	AG09309	skin:	n/a	n/a
38	CTCF	chr8:1926300-1926450	HBMEC	blood vessel:	n/a	n/a
39	CTCF	chr8:1933377-1933603	K562	blood:	n/a	chr8:1933520-1933536
40	CTCF	chr8:1926280-1926430	HPF	lung:	n/a	n/a
41	CTCF	chr8:1933400-1933550	RPTEC	kidney:	n/a	chr8:1933520-1933536
42	CTCF	chr8:1949795-1950242	Fibrobl	skin:	n/a	n/a
43	CTCF	chr8:1926060-1926210	HFF	foreskin:	n/a	n/a
44	CTCF	chr8:1926220-1926370	HRE	kidney:	n/a	n/a
45	CTCF	chr8:1926200-1926350	NHEK	skin:	n/a	n/a
46	CTCF	chr8:1949480-1949630	NHDF-neo	bronchial:	n/a	n/a
47	CTCF	chr8:1926260-1926410	HPAF	blood vessel:	n/a	n/a
48	CTCF	chr8:1951000-1951150	NB4	blood:	n/a	n/a
49	CTCF	chr8:1921820-1921970	Caco-2	colon:	n/a	n/a
50	CTCF	chr8:1950040-1950190	SAEC	small airway:	n/a	n/a

(count:2015 , 50 per page) page: 1 2 3 4 5 6 7 ... 41

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:1922372-1922422	SK-N-MC	brain:	n/a
2	chr8:1922372-1922422	CMK	blood:	n/a
3	chr8:1922372-1922422	SK-N-MC	brain:	n/a
4	chr8:1922372-1922422	CMK	blood:	n/a
5	chr8:1923052-1923102	HRPEpiC	eye:	n/a
6	chr8:1920950-1921000	Jurkat	blood:	n/a
7	chr8:1921328-1921378	PrEC	prostate:	n/a
8	chr8:1940523-1940573	MCF-7	breast:	n/a
9	chr8:1923115-1923165	PFSK-1	brain:	n/a
10	chr8:1940413-1940463	RPTEC	kidney:	n/a
11	chr8:1948999-1949049	GM06990	blood:	n/a
12	chr8:1921165-1921215	ECC-1	luminal epithelium:	n/a
13	chr8:1935720-1935770	NB4	blood:	n/a
14	chr8:1933651-1933701	NT2-D1	testis:	n/a
15	chr8:1921165-1921215	HAEpiC	amniotic membrane:	n/a
16	chr8:1921369-1921419	HCT-116	colon:	n/a
17	chr8:1921906-1921956	PFSK-1	brain:	n/a
18	chr8:1950112-1950162	HCPEpiC	choroid plexus:	n/a
19	chr8:1942462-1942512	HRPEpiC	eye:	n/a
20	chr8:1922165-1922215	GM12891	blood:	n/a
21	chr8:1949329-1949379	ECC-1	luminal epithelium:	n/a
22	chr8:1923115-1923165	HAEpiC	amniotic membrane:	n/a
23	chr8:1923115-1923165	HCF	heart:	n/a
24	chr8:1933522-1933572	NH-A	brain:	n/a
25	chr8:1921906-1921956	GM06990	blood:	n/a
26	chr8:1948874-1948924	U87	brain:	n/a
27	chr8:1921328-1921378	LNCaP	prostate:	n/a
28	chr8:1947038-1947088	HEK293	kidney:	embryo
29	chr8:1921369-1921419	PrEC	prostate:	n/a
30	chr8:1922165-1922215	SK-N-SH_RA	brain:	n/a
31	chr8:1938554-1938604	SAEC	small airway:	n/a
32	chr8:1923052-1923102	HCT-116	colon:	n/a
33	chr8:1923052-1923102	NHDF-neo	bronchial:	n/a
34	chr8:1922372-1922422	NHBE	bronchial:	n/a
35	chr8:1921328-1921378	GM12878	blood:	n/a
36	chr8:1949342-1949392	HPAEpiC	pulmonary alveolar:	n/a
37	chr8:1938554-1938604	PANC-1	pancreas:	n/a
38	chr8:1924394-1924444	RPTEC	kidney:	n/a
39	chr8:1922165-1922215	HCM	heart:	n/a
40	chr8:1933651-1933701	HPAEpiC	pulmonary alveolar:	n/a
41	chr8:1949329-1949379	GM12891	blood:	n/a
42	chr8:1949329-1949379	PrEC	prostate:	n/a
43	chr8:1920950-1921000	HCM	heart:	n/a
44	chr8:1923115-1923165	AG04449	skin:	fetal
45	chr8:1935720-1935770	LNCaP	prostate:	n/a
46	chr8:1950120-1950170	PrEC	prostate:	n/a
47	chr8:1948874-1948924	LNCaP	prostate:	n/a
48	chr8:1947038-1947088	HRPEpiC	eye:	n/a
49	chr8:1940413-1940463	HIPEpiC	eye:	n/a
50	chr8:1933651-1933701	HL-60	blood:	n/a

(count:14 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:1945649..1948332-chr8:1948376..1949994,2	MCF-7	breast:
2	chr8:1923575..1926096-chr8:1929371..1931428,2	K562	blood:
3	chr17:8339151..8339685-chr8:1949081..1949841,2	Hela-S3	cervix:
4	chr8:1945649..1948332-chr8:1948376..1949994,2	MCF-7	breast:
5	chr8:1920801..1923588-chr8:1929639..1933248,3	MCF-7	breast:
6	chr8:1947283..1948870-chr8:1955148..1956732,2	MCF-7	breast:
7	chr8:1862307..1864338-chr8:1926078..1927839,2	K562	blood:
8	chr8:1939104..1942044-chr8:1945221..1947708,2	MCF-7	breast:
9	chr8:1939104..1942044-chr8:1945221..1947708,2	MCF-7	breast:
10	chr8:1923575..1926096-chr8:1929371..1931428,2	K562	blood:
11	chr8:1920209..1923568-chr8:1948553..1950993,3	MCF-7	breast:
12	chr1:8021103..8021603-chr8:1931796..1932353,2	HCT-116	colon:
13	chr8:1906659..1908488-chr8:1948019..1949630,2	MCF-7	breast:
14	chr8:1920180..1923138-chr8:1945737..1947399,2	MCF-7	breast:

(count:10 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CSMD1-7	chr8:1920736-1920829	ENSG00000253764.1
2	lnc-KBTBD11-1	chr8:1920091-1920518	NONHSAT124693
3	lnc-CSMD1-7	chr8:1922773-1922803	ENSG00000253764.1
4	lnc-CSMD1-7	chr8:1921314-1921511	ENSG00000253764.1
5	lnc-ARHGEF10-1	chr8:1922984-1923480	ENSG00000270988.1
6	lnc-KBTBD11-1	chr8:1924065-1924644	ENSG00000253696.2
7	lnc-KBTBD11-1	chr8:1924065-1924610	ENSG00000253696.1
8	lnc-KBTBD11-1	chr8:1919296-1920689	NONHSAT124692
9	lnc-CSMD1-7	chr8:1921314-1921776	ENSG00000253764.1
10	lnc-CSMD1-7	chr8:1920987-1921202	ENSG00000253764.1

No data

Variant related genes	Relation type
ENSG00000270988	TF binding region
KBTBD11	TF binding region
ENSG00000253764	TF binding region
ENSG00000270988	CpG island
KBTBD11	CpG island
ENSG00000253764	CpG island
ENSG00000253764	chromatin interactions
ENSG00000176595	chromatin interactions
ENSG00000166579	chromatin interactions
ENSG00000270988	chromatin interactions

Extended variants
information (count: 1870 )
Associated
traits (count: 117 )

Variant overlapped rSNPs/rCNVs (count:1870 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4242546	chr8:1920461-1920462	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs541367122	chr8:1920471-1920472	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
3	rs546181649	chr8:1920472-1920473	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
4	rs529954373	chr8:1920481-1920482	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
5	rs549717055	chr8:1920503-1920504	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
6	rs569284243	chr8:1920509-1920510	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
7	rs531732162	chr8:1920526-1920527	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
8	rs146902697	chr8:1920532-1920533	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
9	rs551717408	chr8:1920600-1920601	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
10	rs571341431	chr8:1920611-1920612	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
11	rs534200661	chr8:1920619-1920620	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
12	rs4242545	chr8:1920626-1920627	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs556046813	chr8:1920648-1920649	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
14	rs567629466	chr8:1920744-1920745	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
15	rs536806131	chr8:1920749-1920750	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
16	rs145740844	chr8:1920752-1920753	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
17	rs576054008	chr8:1920753-1920754	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
18	rs371104981	chr8:1920758-1920759	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
19	rs538390781	chr8:1920775-1920776	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
20	rs534296410	chr8:1920779-1920780	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
21	rs181216338	chr8:1920781-1920782	Weak transcription Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
22	rs375509244	chr8:1920809-1920810	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	lncRNA	n/a	Overlapped CNVs	n/a
23	rs148198280	chr8:1920810-1920811	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	lncRNA	n/a	Overlapped CNVs	n/a
24	rs541326192	chr8:1920823-1920824	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	lncRNA	n/a	Overlapped CNVs	n/a
25	rs140310874	chr8:1920824-1920825	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	lncRNA	n/a	Overlapped CNVs	n/a
26	rs140089004	chr8:1920831-1920832	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
27	rs78286946	chr8:1920863-1920864	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs543121819	chr8:1920885-1920886	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs543573634	chr8:1920894-1920895	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs564294361	chr8:1920918-1920919	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs531815886	chr8:1920920-1920921	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs112114137	chr8:1920971-1920972	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
33	rs564934226	chr8:1920972-1920973	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
34	rs7813168	chr8:1920977-1920978	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
35	rs547391222	chr8:1920982-1920983	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
36	rs567592752	chr8:1921003-1921004	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
37	rs528774786	chr8:1921038-1921039	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
38	rs550335368	chr8:1921054-1921055	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
39	rs186785415	chr8:1921083-1921084	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
40	rs370703449	chr8:1921095-1921096	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
41	rs138028480	chr8:1921103-1921104	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
42	rs116941897	chr8:1921111-1921112	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
43	rs142595160	chr8:1921118-1921119	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
44	rs191631896	chr8:1921124-1921125	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
45	rs554624678	chr8:1921135-1921136	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
46	rs574638915	chr8:1921136-1921137	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
47	rs543384811	chr8:1921154-1921155	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
48	rs4557743	chr8:1921160-1921161	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs577010102	chr8:1921190-1921191	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island lncRNA	2 gene(s)	Overlapped CNVs	n/a
50	rs545088758	chr8:1921204-1921205	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:117)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Cancer	18840272	CNVD
Pilocytic astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
Ductal carcinoma	22052326	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Epilepsy	22083797	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Breast cancer	20932292	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Ependymoma	20639864	CNVD
Ovarian cancer	22355333	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22297974	CNVD

Chromatin state (count:1362 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:1905600-1921000	Weak transcription	Aorta	Aorta
2	chr8:1906600-1921000	Weak transcription	Right Ventricle	heart
3	chr8:1912000-1920600	Weak transcription	Cortex derived primary cultured neurospheres	brain
4	chr8:1912200-1920800	Weak transcription	Brain Hippocampus Middle	brain
5	chr8:1913600-1921200	Weak transcription	Esophagus	oesophagus
6	chr8:1914600-1921200	Weak transcription	Left Ventricle	heart
7	chr8:1914800-1921000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr8:1914800-1921200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
9	chr8:1916600-1920800	Weak transcription	HSMMtube	muscle
10	chr8:1916600-1921200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
11	chr8:1916800-1920800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr8:1916800-1920800	Weak transcription	Muscle Satellite Cultured Cells	--
13	chr8:1916800-1920800	Weak transcription	Fetal Heart	heart
14	chr8:1916800-1921000	Weak transcription	HSMM	muscle
15	chr8:1918600-1921000	Weak transcription	Small Intestine	intestine
16	chr8:1918800-1921000	Enhancers	Liver	Liver
17	chr8:1919000-1921000	Enhancers	Fetal Muscle Leg	muscle
18	chr8:1919000-1921400	Enhancers	Spleen	Spleen
19	chr8:1919400-1920800	Weak transcription	Brain Germinal Matrix	brain
20	chr8:1919400-1921000	Enhancers	Primary B cells from peripheral blood	blood
21	chr8:1919600-1920600	Weak transcription	Fetal Intestine Small	intestine
22	chr8:1919600-1923000	Active TSS	Duodenum Mucosa	Duodenum
23	chr8:1919800-1920800	Enhancers	Primary B cells from cord blood	blood
24	chr8:1919800-1920800	Enhancers	Fetal Kidney	kidney
25	chr8:1919800-1920800	Weak transcription	Fetal Stomach	stomach
26	chr8:1919800-1921000	Weak transcription	Fetal Intestine Large	intestine
27	chr8:1919800-1923200	Active TSS	Rectal Mucosa Donor 29	rectum
28	chr8:1920000-1920800	Enhancers	Fetal Brain Female	brain
29	chr8:1920000-1920800	Enhancers	Rectal Mucosa Donor 31	rectum
30	chr8:1920000-1921000	Weak transcription	Fetal Brain Male	brain
31	chr8:1920000-1921000	Weak transcription	Fetal Lung	lung
32	chr8:1920000-1921000	Weak transcription	Sigmoid Colon	Sigmoid Colon
33	chr8:1920000-1922400	Active TSS	Colonic Mucosa	Colon
34	chr8:1920400-1920600	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
35	chr8:1920400-1920600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr8:1920400-1920600	Enhancers	Pancreas	Pancrea
37	chr8:1920400-1920800	Enhancers	Primary hematopoietic stem cells	blood
38	chr8:1920400-1920800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
39	chr8:1920400-1920800	Enhancers	Fetal Muscle Trunk	muscle
40	chr8:1920400-1920800	Enhancers	Dnd41	blood
41	chr8:1920600-1920800	Enhancers	Primary neutrophils fromperipheralblood	blood
42	chr8:1920600-1920800	Enhancers	Primary T cells from cord blood	blood
43	chr8:1920600-1920800	Enhancers	Primary T cells fromperipheralblood	blood
44	chr8:1920600-1920800	Enhancers	Primary T helper naive cells from peripheral blood	blood
45	chr8:1920600-1920800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
46	chr8:1920600-1920800	Enhancers	Primary T helper cells PMA-I stimulated	--
47	chr8:1920600-1920800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr8:1920600-1920800	Enhancers	Cortex derived primary cultured neurospheres	brain
49	chr8:1920600-1920800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
50	chr8:1920600-1920800	Enhancers	Brain Cingulate Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links